In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation
W. Barcellini et al., In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation, BR J HAEM, 111(2), 2000, pp. 452-460
The immunopathogenic mechanisms underlying idiopathic autoimmune haemolytic
anaemia (AIHA) are still unknown, although regulatory cytokines are though
t to play an important role. We investigated cytokine production by mitogen
-stimulated whole blood cultures from 21 patients with AIHA and from 22 age
- and sex-matched controls. In parallel experiments, we studied the effect
of mitogen and cytokine stimulation on anti-red blood cell (RBC) IgG antibo
dy production, assessed as both binding on autologous RBCs and secretion in
culture supernatants. To quantify anti-RBC antibody, we set up a sensitive
and quantitative solid phase competitive immunoassay. The results showed t
hat in AIHA patients production of interleukin (IL)-4, IL-6 and IL-13 was s
ignificantly increased, whereas that of interferon (IFN)-gamma was reduced.
Multivariate analysis showed that IFN-gamma was the only independent facto
r significantly associated with the reduced T-helper-1-like cytokine profil
e. Patients with active haemolysis showed further reduction of IFN-gamma an
d IL-2 production and increased secretion of transforming growth factor (TG
F)-beta. In AIHA patients, mitogen stimulation, as well as IL-6, significan
tly increased autologous anti-RBC-binding relative to unstimulated cultures
. Mitogen stimulation and addition of IL-4, IL-6, IL-10, IL-13 and TGF-beta
significantly increased both autologous anti-RBC binding and antibody secr
etion in AIHA patients compared with controls. The results suggest that a r
educed T-helper-1- and a predominant T-helper-2-like profile and elevated T
GF-beta levels might play a role in the immunopathogenesis of AIHA. Further
more, our competitive anti-RBC antibody was able to detect anti-RBC antibod
y production in some direct antiglobulin test (DAT)-negative AIHA patients.